InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（1 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the detailed record of transactions filed by Andrews Nancy C, Director. Director active across 2 companies, notably CHARLES RIVER LABORATORIES INTERNATIONAL, INC.. Aggregated, 8 filings have been published. Split: 0 buy · 1 sell. Total volume traded: €141k. History available since 7 May 2021. The latest transaction was disclosed on 18 August 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Andrews Nancy C
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报8 总计
573 股@ US$164.30Common StockSEC:0001100682-26-000134:0
573 股@ US$285.24Common StockSEC:0001100682-26-000134:1
3,964 股0Common StockSEC:0001100682-26-000073:0
946 股@ US$134.9848.8% 占其流量Common StockSEC:0001127602-25-015469:0
559 股@ US$228.4151.2% 占其流量Common StockSEC:0001127602-24-015536:0
664 股0Common StockSEC:0001127602-23-015839:0
575 股0Common StockSEC:0001127602-22-014388:0
355 股0Common StockSEC:0001127602-21-016096:0
8 条申报中的 8 条
About Andrews Nancy C
Nancy C. Andrews is a Director at Charles River Laboratories International, Inc. She plays an important role in the governance of the company, which focuses on research and development services. Andrews contributes to strategic decision-making and the direction of the company's policy, ensuring that Charles River Laboratories remains competitive in the market.
